[(177)Lu]Lu-PSMA-617 in PSMA-positive metastatic castration-resistant prostate cancer: Prior and concomitant treatment subgroup analyses of the VISION trial Meeting Abstract


Authors: Vaishampayan, N.; Morris, M. J.; Krause, B. J.; Vogelzang, N. J.; Kendi, A. T.; Nordquist, L. T.; Calais, J.; Nagarajah, J.; Beer, T. M.; El-Haddad, G.; Brackman, M.; Desilvio, M.; Messmann, R. A.; Sartor, A. O.; Fizazi, K.
Abstract Title: [(177)Lu]Lu-PSMA-617 in PSMA-positive metastatic castration-resistant prostate cancer: Prior and concomitant treatment subgroup analyses of the VISION trial
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680301420
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.5001
Notes: Meeting Abstract: 5001 -- Meeting also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris